医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

C.C.Medico Announces the Launch of Wrapping Foundation AirSkin®, the Cosmetic That Exquisitely Wraps You Like a Lovely Gift

2014年12月23日 AM02:30
このエントリーをはてなブックマークに追加


 

TOKYO

C.C.Medico.Co., Ltd. has developed AirSkin®, a wrapping foundation that exquisitely wraps your skin like a lovely gift with an attractive wrapping film. AirSkin® is not spread on like previous cosmetic products. It is a completely new type of cover-up foundation that uses a microns-thick skin-colored film that users apply to their skin.

YouTube “This is AirSkin ® (60 seconds)”

Although we at C.C.Medico have been involved in developing cover-up cosmetic products to hide blemishes, bruises, dullness, and surgical and natural scars, we were never able to develop a product that could completely cover these skin conditions using liquid or powder based cosmetics.

We discovered from a member of our testing group , that they would conceal tattoos using tape. This led us to move from developing spread-on foundation to engage in the development of an applied foundation.

Since this newly perfected AirSkin® is based on a method that transfers a microns-thick skin-colored film onto the user’s skin, it has several advantages over previous foundations. These include the ability to cover uniformly without blotches as well as greatly improved water resistance, scratch resistance, and durability.

Starting this Christmas, we will deliver AirSkin® – the product that will exquisitely wrap you like a dazzling gift – to the world.

WEB SHOP SANNA’S (Payment accepted in USD, EUR, BRL, and JPY)

In English

In Portuguese

In Spanish

[Company Overview]

Website

AirSkin Website

CONTACT

C.C.Medico Co.,Ltd.
Mayu Ishikawa, +81-3-5942-5536
ccmedico@me.com
fax:
+81-3-5542-5529

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd)
  • Genexine Announces Dosing of First Patient in Phase 2 clinical trial with Triple Combination Therapy in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
  • クリアがCOVID-19声明に関する政府の訴訟に対して修正答弁書を提出、クリア製品の追加防御層としての使用を支持するデータをさらに提供
  • Integral Group Australia Rebranding as Introba to Align with Global Brands
  • 针对政府就新冠病毒声明提起的诉讼,Xlear提交修正后的答复;通过更多数据继续支持Xlear作为额外防护层使用